IsoRay Net Profit Margin 2006-2020 | ISR

IsoRay net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
IsoRay Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.01B $-0.00B -44.44%
2020-03-31 $0.01B $-0.00B -44.44%
2019-12-31 $0.01B $-0.00B -50.00%
2019-09-30 $0.01B $-0.00B -50.00%
2019-06-30 $0.01B $-0.01B -62.50%
2019-03-31 $0.01B $-0.01B -75.00%
2018-12-31 $0.01B $-0.01B -75.00%
2018-09-30 $0.01B $-0.01B -75.00%
2018-06-30 $0.01B $-0.01B -85.71%
2018-03-31 $0.01B $-0.01B -100.00%
2017-12-31 $0.01B $-0.01B -120.00%
2017-09-30 $0.00B $-0.01B -150.00%
2017-06-30 $0.00B $-0.01B -150.00%
2017-03-31 $0.00B $-0.01B -125.00%
2016-12-31 $0.00B $-0.01B -125.00%
2016-09-30 $0.00B $-0.01B -125.00%
2016-06-30 $0.00B $-0.00B -100.00%
2016-03-31 $0.00B $-0.00B -100.00%
2015-12-31 $0.00B $-0.00B -100.00%
2015-09-30 $0.00B $-0.00B -100.00%
2015-06-30 $0.00B $-0.00B -100.00%
2015-03-31 $0.00B $-0.01B -125.00%
2014-12-31 $0.00B $-0.01B -150.00%
2014-09-30 $0.00B $-0.01B -150.00%
2014-06-30 $0.00B $-0.01B -175.00%
2014-03-31 $0.00B $-0.01B -150.00%
2013-12-31 $0.00B $-0.01B -125.00%
2013-09-30 $0.00B $-0.01B -125.00%
2013-06-30 $0.00B $-0.00B -100.00%
2013-03-31 $0.00B $-0.00B -100.00%
2012-12-31 $0.00B $-0.00B -100.00%
2012-09-30 $0.00B $-0.00B -100.00%
2012-06-30 $0.00B $-0.00B -100.00%
2012-03-31 $0.00B $-0.00B -100.00%
2011-12-31 $0.00B $-0.00B -100.00%
2011-09-30 $0.00B $-0.00B -75.00%
2011-06-30 $0.00B $-0.00B -75.00%
2011-03-31 $0.00B $-0.00B -75.00%
2010-12-31 $0.00B $-0.00B -75.00%
2010-09-30 $0.00B $-0.00B -100.00%
2010-06-30 $0.00B $-0.00B -100.00%
2010-03-31 $0.00B $-0.00B -100.00%
2009-12-31 $0.00B $-0.00B -100.00%
2009-09-30 $0.00B $-0.01B -125.00%
2009-06-30 $0.01B $-0.01B -120.00%
2009-03-31 $0.01B $-0.01B -100.00%
2008-12-31 $0.01B $-0.01B -100.00%
2008-09-30 $0.01B $-0.01B -100.00%
2008-06-30 $0.01B $-0.01B -100.00%
2008-03-31 $0.01B $-0.01B -125.00%
2007-12-31 $0.01B $-0.01B -125.00%
2007-09-30 $0.01B $-0.01B -128.57%
2007-06-30 $0.01B $-0.01B -166.67%
2007-03-31 $0.01B $-0.01B -200.00%
2006-12-31 $0.00B $-0.01B -333.33%
2006-09-30 $0.00B $-0.01B -500.00%
2006-06-30 $0.00B $-0.01B -900.00%
2006-03-31 $0.00B $-0.01B inf%
2005-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.028B $0.010B
IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device. The Company competes with Varian Medical Systems, Siemens Healthcare, Elekta AB and Accuray Incorporated.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.876B 43.16
Takeda Pharmaceutical (TAK) Japan $52.556B 9.16
Astellas Pharma (ALPMY) Japan $26.149B 0.00
Eisai (ESALY) Japan $24.410B 20.63
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $18.992B 24.91
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.326B 49.82
Grifols, S.A (GRFS) Spain $13.428B 16.41
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 24.00
Neurocrine Biosciences (NBIX) United States $9.232B 35.74
Jazz Pharmaceuticals (JAZZ) Ireland $8.231B 13.62
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.178B 0.00
IPSEN SA ADR (IPSEY) France $7.738B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.622B 41.95
Orion OYJ (ORINY) Finland $6.484B 22.50
Arrowhead Pharmaceuticals (ARWR) United States $5.599B 0.00
United Therapeutics (UTHR) United States $5.293B 12.23
Evotec AG (EVTCY) Germany $4.189B 145.40
FibroGen (FGEN) United States $4.110B 0.00
ChemoCentryx (CCXI) United States $3.682B 0.00
Sage Therapeutics (SAGE) United States $3.642B 0.00
PTC Therapeutics (PTCT) United States $3.487B 0.00
Hypermarcas (HYPMY) Brazil $3.408B 12.53
Nektar Therapeutics (NKTR) United States $3.072B 0.00
Revolution Medicines (RVMD) United States $2.815B 0.00
Xencor (XNCR) United States $2.283B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.276B 11.02
Pacira BioSciences (PCRX) United States $2.264B 59.52
Corcept Therapeutics (CORT) United States $2.055B 18.92
Cronos Group (CRON) Canada $1.987B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.936B 0.00
USANA Health Sciences (USNA) United States $1.632B 14.38
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.561B 14.89
Ironwood Pharmaceuticals (IRWD) United States $1.523B 10.58
Heron Therapeutics (HRTX) United States $1.399B 0.00
Trillium Therapeutics (TRIL) Canada $1.336B 0.00
Endo (ENDP) Ireland $1.333B 1.97
Theravance Biopharma (TBPH) Cayman Islands $1.177B 0.00
Zogenix (ZGNX) United States $1.119B 0.00
Karyopharm Therapeutics (KPTI) United States $1.087B 0.00
Translate Bio (TBIO) United States $1.064B 0.00
Indivior (INVVY) United States $1.037B 12.85
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Esperion Therapeutics (ESPR) United States $0.932B 0.00
ImmunoGen (IMGN) United States $0.916B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.872B 542.88
Tilray (TLRY) Canada $0.796B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.732B 0.00
Collegium Pharmaceutical (COLL) United States $0.683B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.668B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.653B 32.55
BioCryst Pharmaceuticals (BCRX) United States $0.620B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Flexion Therapeutics (FLXN) United States $0.601B 0.00
VAXART, INC (VXRT) United States $0.585B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.516B 55.08
Akebia Therapeutics (AKBA) United States $0.513B 0.00
Molecular Templates (MTEM) United States $0.510B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.493B 0.00
Ardelyx (ARDX) United States $0.471B 0.00
TherapeuticsMD (TXMD) United States $0.441B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.434B 0.00
Aerie Pharmaceuticals (AERI) United States $0.424B 0.00
Organogenesis Holdings (ORGO) United States $0.422B 0.00
Harpoon Therapeutics (HARP) United States $0.381B 0.00
DURECT (DRRX) United States $0.375B 0.00
Altimmune (ALT) United States $0.375B 0.00
Redhill Biopharma (RDHL) Israel $0.367B 0.00
Profound Medical (PROF) Canada $0.347B 0.00
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Jounce Therapeutics (JNCE) United States $0.330B 15.65
Catalyst Pharmaceuticals (CPRX) United States $0.330B 8.18
Menlo Therapeutics (VYNE) United States $0.325B 0.00
MEI Pharma (MEIP) United States $0.318B 0.00
Innate Pharma SA (IPHYF) France $0.313B 0.00
KalVista Pharmaceuticals (KALV) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.301B 0.00
Lannett Co Inc (LCI) United States $0.282B 6.54
Rafael Holdings (RFL) United States $0.272B 0.00
Aduro Biotech (KDNY) United States $0.271B 0.00
Calithera Biosciences (CALA) United States $0.265B 0.00
Xeris Pharmaceuticals (XERS) United States $0.243B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
CTI BioPharma (CTIC) United States $0.239B 0.00
IMV INC (IMV) Canada $0.236B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 22.54
Summit Therapeutics (SMMT) United Kingdom $0.219B 0.00
CASI Pharmaceuticals (CASI) United States $0.200B 0.00
Aclaris Therapeutics (ACRS) United States $0.193B 0.00
Nivalis Therapeutics (ALPN) United States $0.191B 0.00
Otonomy (OTIC) United States $0.179B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
OptiNose (OPTN) United States $0.175B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.172B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.169B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.109B 0.00
MediWound (MDWD) Israel $0.101B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Lipocine (LPCN) United States $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.088B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.080B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.080B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.078B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Novan (NOVN) United States $0.071B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.066B 0.00
AgeX Therapeutics (AGE) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.052B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.09
Forward Pharma (FWP) Denmark $0.044B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.86
GTx (ONCT) United States $0.034B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Vical (BBI) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 26.89
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00